NEW YORK (GenomeWeb News) – Response Genetics reported after the close of the market Thursday that its second-quarter revenues increased 4 percent on strong sales growth for its ResponseDx pharmacogenomic tests.

The Los Angeles-based firm reported total revenues of $1.9 million for the three-month period ended June 30, up from $1.8 million for the second quarter of 2008. It said that sales of its ResponseDx genetic tests increased 70 percent from the previous quarter to a total of $446,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.